Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(9%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
5
45%
Ph not_applicable
2
18%
Ph phase_3
4
36%

Phase Distribution

0

Early Stage

0

Mid Stage

9

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
4(36.4%)
Phase 4Post-market surveillance
5(45.5%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(8)
Other(2)

Detailed Status

Completed8
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 34 (36.4%)
Phase 45 (45.5%)
N/A2 (18.2%)

Trials by Status

completed873%
unknown218%
recruiting19%

Recent Activity

1 active trials
Showing 5 of 11
recruitingphase_3

Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage

NCT05245227
unknownnot_applicable

Sublingual Versus Vaginal Misoprostol In Medical Treatment of Second Trimestric Missed Miscarriage

NCT05088707
completedphase_3

Sublingual vs Intrauterine MISOPROSTOL Plus Oxytocin Infusion for Prevention of Post-cesarean Hemorrhage in High Risk Pregnant Women: A Double-blind Placebo RCT

NCT04560218
completedphase_4

Rectal Misoprostol Versus Sublingual Misoprostol Prior to Myomectomy

NCT02716142
completedphase_4

Sublingual Misoprostol for Induction of Labor

NCT01406392
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT05245227Phase 3

Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage

Recruiting
NCT05088707Not Applicable

Sublingual Versus Vaginal Misoprostol In Medical Treatment of Second Trimestric Missed Miscarriage

Unknown
NCT04560218Phase 3

Sublingual vs Intrauterine MISOPROSTOL Plus Oxytocin Infusion for Prevention of Post-cesarean Hemorrhage in High Risk Pregnant Women: A Double-blind Placebo RCT

Completed
NCT02716142Phase 4

Rectal Misoprostol Versus Sublingual Misoprostol Prior to Myomectomy

Completed
NCT01406392Phase 4

Sublingual Misoprostol for Induction of Labor

Completed
NCT02686840Phase 3

Sublingual Versus Vaginal Misoprostol In Medical Treatment of First Trimestric Missed Miscarriage

Completed
NCT02708446Phase 4

A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester Abortion

Unknown
NCT02732522Phase 4

Comparison Between Vaginal and Sublingual Misoprostol 50 µg for Cervical Ripening Prior to Induction of Labor

Completed
NCT02720991Phase 4

A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks

Completed
NCT01805115Phase 3

Misoprostol Administration Before Operative Hysteroscopy

Completed
NCT01718314Not Applicable

Comparison of Sublingual Misoprostol Versus Lidocaine Spray for Hysteroscopy

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11